Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial

Tay, RY; Fernandez-Gutierrez, F; Foy, V; Burns, K; Pierce, J; Morris, K; Priest, L; Tugwood, J; Ashcroft, L; Lindsay, CR; Faiyre-Finn, C; Dive, C; Blackhal, F

Blackhal, F (reprint author), Christie NHS Fdn Trust, Dept Med Oncol, 550 Wilmslow Rd, Manchester M20 4BK, Lancs, England.; Blackhal, F (reprint author), Univ Manchester, Div Mol & Clin Canc Sci, 550 Wilmslow Rd, Manchester M20 4BK, Lancs, England.

ANNALS OF ONCOLOGY, 2019; 30 (7): 1114

Abstract

Background The clinical significance of circulating tumour cells (CTCs) in limited-stage small-cell lung cancer (LS-SCLC) is not well defined. We repo......

Full Text Link